Work

Novel molecular therapies for coronary stents

Year: 2018
Type: dissertation
Abstract: Cardiovascular diseases are the leading cause of morbidity and mortality across the world with atherosclerotic disease, which manifests typically as coronary artery disease and stroke, causing a majority of the disease burden.The restriction to blood flow from narrowing of arteries is managed with medical therapy, surgery or device-based treatments, which have seen significant developments during the last years.Coronary stents are designed to keep an artery open after catheter-based balloon angioplasty.Current stents can be coated with drugs to prevent re-stenosis while the same drugs may have harmful effects on the endothelial lining of the artery.We studied a stent coated with a synthetic PPAR-δ agonist for its properties in prevention of restenosis and enhancement of vascular healing.The stent was found to reduce restenosis in an atherosclerotic model and found to have anti-inflammatory and antithrombotic properties.In another approach, we investigated the feasibility of catheter-based delivery of a gene medicine to the adventitial space.A locally administered anti-angiogenic therapy with adenoviruses encoding soluble vascular endothelial growth factor receptors (sVEGFRs) reduced the vasa-vasorum vessel growth around the stent.Following attenuated angiogenesis, the stents developed less in-stent restenosis in longer follow-up.A coronary stent prevents arterial recoil post stenting.While a strong mechanical support is necessary in the short term, a permanent implant may even be harmful.Fully biodegradable coronary scaffolds have been introduced and we examined a biodegradable stent in a preclinical model by repeat intravascular imaging for acute and chronic changes.Biodegradable devices showed more recoil compared to traditional metal stents, although the biodegradable devices adapted to changes in the size and structure of the artery.In summary, existing stent technologies can be used in conjunction with locally administered therapies including gene therapy with a goal of affecting beneficially the arterial wall microenvironment.New stent technologies will likely further combine biodegradable materials with novel therapeutic agents to achieve better outcomes.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W3182053305
Cites: 219
Cited by:
Related to: 10